Zepbound sales keep soaring, despite demand for weight-loss drugs growing slower than expected ...Middle East

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter, despite missing the company’s initial sales expectations.

Read more...

Read More Details
Finally We wish PressBee provided you with enough information of ( Zepbound sales keep soaring, despite demand for weight-loss drugs growing slower than expected )

Also on site :

• Spain and Portugal Hit by Widespread Blackout
• BYD is coming for Tesla's lunch
• Deliveroo shares soar to three-year high after U.S. giant DoorDash makes takeover bid